Adjupanrix Pandemic Influenza Vaccine (split virion, inactivated, AS03 adjuvanted) Medication Singapore | Shim Clinic
| Help me about Adjupanrix Pandemic Influenza Vaccine (split virion, inactivated, AS03 adjuvanted) Medication ! |
| Permalink: https://shimclinic.sg/meds/adjupanrix-pandemic-influenza-vaccine-split-virion-inactivated-as03-adjuvanted |
Adjupanrix Pandemic Influenza Vaccine (split virion, inactivated, AS03 adjuvanted) is a medication in Singapore. The dosage in INJECTION, EMULSION form, is administered by the INTRAMUSCULAR route. The licence is held by GLAXOSMITHKLINE PTE LTD, approved on 2017-05-17, with the number SIN15239P. The forensic classification is Prescription Only, and ATC code is J07BB02.
Medications > Product Name > Adjupanrix Pandemic Influenza Vaccine (split virion, inactivated, AS03 adjuvanted)
- Licence Number: SIN15239P
- Product Name: Adjupanrix Pandemic Influenza Vaccine (split virion, inactivated, AS03 adjuvanted)
- License Holder: GLAXOSMITHKLINE PTE LTD
- Approval Date: 2017-05-17
- Forensic Classification: Prescription Only
- Atc Code: J07BB02
- Dosage Form: INJECTION, EMULSION
- Route Of Administration: INTRAMUSCULAR
- Manufacturer & Country Of Manufacturer:
- Glaxo Operations UK Ltd., (trading as Glaxo Wellcome Operations) (Antigen: filling) – BELGIUM
- GlaxoSmithKline Biologicals S.A. (Antigen: filling) – UNITED KINGDOM
- GlaxoSmithKline Biologicals S.A. (Adjuvant: formulation & filling) – GERMANY
- GSK Biologicals SA (Adjuvant: formulation & secondary packager) –
- GlaxoSmithKline Biologicals (Antigen) –
- Active Ingredients & Strength:
References